184 related articles for article (PubMed ID: 16723247)
21. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass.
Abacilar F; Dogan OF; Duman U; Ucar I; Demircin M; Ersoy U; Dogan R; Boke E
Heart Surg Forum; 2006; 9(4):E703-9. PubMed ID: 16844625
[TBL] [Abstract][Full Text] [Related]
22. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
[TBL] [Abstract][Full Text] [Related]
23. Alterations in plasma complement levels after human ischemic stroke.
Mocco J; Wilson DA; Komotar RJ; Sughrue ME; Coates K; Sacco RL; Elkind MS; Connolly ES
Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
[TBL] [Abstract][Full Text] [Related]
24. Effect of cardiopulmonary bypass on neutrophil activity in pediatric open-heart surgery.
Paśnik J; Siniewicz K; Moll JA; Moll J; Baj Z; Sysa A; Zeman K
Arch Immunol Ther Exp (Warsz); 2005; 53(3):272-7. PubMed ID: 15995588
[TBL] [Abstract][Full Text] [Related]
25. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
[TBL] [Abstract][Full Text] [Related]
26. Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation.
Goebel U; Siepe M; Mecklenburg A; Doenst T; Beyersdorf F; Loop T; Schlensak C
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1165-72. PubMed ID: 18829339
[TBL] [Abstract][Full Text] [Related]
27. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation.
Matsuzaki K; Hiramatsu Y; Homma S; Sato S; Shigeta O; Sakakibara Y
Ann Thorac Surg; 2005 Aug; 80(2):611-7. PubMed ID: 16039215
[TBL] [Abstract][Full Text] [Related]
28. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
Kreutzer DL; McCormick JR; Despins A; Moore M; Rousou JH; Dobbs W; Engleman RN
J Exp Pathol; 1984; 1(3):183-7. PubMed ID: 6336305
[TBL] [Abstract][Full Text] [Related]
30. TNF-alpha inhibits toll-like receptor 4 expression on monocytic cells via tristetraprolin during cardiopulmonary bypass.
Tsai CS; Chen DL; Lin SJ; Tsai JC; Lin TC; Lin CY; Chen YH; Huang GS; Tsai HY; Lin FY; Li CY
Shock; 2009 Jul; 32(1):40-8. PubMed ID: 19106809
[TBL] [Abstract][Full Text] [Related]
31. Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model.
Shao H; Shen Y; Liu H; Dong G; Qiang J; Jing H
Ann Thorac Surg; 2007 Dec; 84(6):2011-8. PubMed ID: 18036927
[TBL] [Abstract][Full Text] [Related]
32. Pulsatile pulmonary perfusion during cardiopulmonary bypass reduces the pulmonary inflammatory response.
Siepe M; Goebel U; Mecklenburg A; Doenst T; Benk C; Stein P; Beyersdorf F; Loop T; Schlensak C
Ann Thorac Surg; 2008 Jul; 86(1):115-22. PubMed ID: 18573409
[TBL] [Abstract][Full Text] [Related]
33. A rat model of cardiopulmonary bypass with cardioplegic arrest and hemodynamic assessment by conductance catheter technique.
Günzinger R; Wildhirt SM; Schad H; Heimisch W; Gurdan M; Mendler N; Grammer J; Lange R; Bauernschmitt R
Basic Res Cardiol; 2007 Nov; 102(6):508-17. PubMed ID: 17668258
[TBL] [Abstract][Full Text] [Related]
34. The use of TP10, soluble complement receptor 1, in cardiopulmonary bypass.
Li JS; Jaggers J; Anderson PA
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):649-54. PubMed ID: 17081086
[TBL] [Abstract][Full Text] [Related]
35. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation.
Graulich J; Sonntag J; Marcinkowski M; Bauer K; Kössel H; Bührer C; Obladen M; Versmold HT
Mediators Inflamm; 2002 Apr; 11(2):69-73. PubMed ID: 12061426
[TBL] [Abstract][Full Text] [Related]
36. Methylprednisolone fails to preserve pulmonary surfactant and blood-air barrier integrity in a porcine cardiopulmonary bypass model.
Mühlfeld C; Liakopoulos OJ; Schaefer IM; Schöndube FA; Richter J; Dörge H
J Surg Res; 2008 May; 146(1):57-65. PubMed ID: 17583746
[TBL] [Abstract][Full Text] [Related]
37. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass.
Undar A; Eichstaedt HC; Clubb FJ; Fung M; Lu M; Bigley JE; Vaughn WK; Fraser CD
Ann Thorac Surg; 2002 Aug; 74(2):355-62; discussion 362. PubMed ID: 12173813
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution.
Ohata T; Mitsuno M; Yamamura M; Tanaka H; Kobayashi Y; Ryomoto M; Yoshioka Y; Tsujiya N; Miyamoto Y
ASAIO J; 2008; 54(2):207-9. PubMed ID: 18356657
[TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of PHISIO-coated sets for pediatric cardiac surgery.
Hoel TN; Thiara AS; Videm V; Fiane AE; Mollnes TE; Castellheim A; Svennevig JL
Scand Cardiovasc J; 2009 Apr; 43(2):129-35. PubMed ID: 19294579
[TBL] [Abstract][Full Text] [Related]
40. The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery.
Murphy GS; Szokol JW; Marymont JH; Avram MJ; Vender JS
Anesth Analg; 2007 Jun; 104(6):1334-42, table of contents. PubMed ID: 17513621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
